Description

Tirzepatide Trio Overview

The Tirzepatide Trio is a research bundle providing three vials of Tirzepatide for extended or comparative laboratory studies. Tirzepatide is a synthetic peptide of interest for its dual activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This bundle allows researchers to explore peptide–receptor interactions, incretin signaling, and metabolic regulation across multiple experiments.

Research Highlights

• Dual Receptor Agonist Studies: Tirzepatide is studied for its combined activity at GIP and GLP-1 receptors, offering unique insights into metabolic pathways.

• Glucose & Lipid Regulation: Provides a research model for studying peptide effects on glucose metabolism, insulin sensitivity, and lipid balance.

• Peptide-Receptor Binding: Valuable for examining structural and functional interactions in incretin pathway activation.

Usage and Safety Information

This bundle is intended for laboratory research purposes only. It is not approved for human or veterinary use. Researchers should follow proper laboratory protocols when handling these peptides.

Disclaimer

All content is provided for educational and scientific research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.

Important Notices

• Supplied as lyophilized (freeze-dried) powders in sterile, sealed vials.

• The bundle contains three vials of Tirzepatide.

• Label amounts refer to the total peptide content per vial.

• Additional laboratory supplies (bacteriostatic water, syringes, alcohol pads) are required for reconstitution.

• Vial design, labels, seals, and cap colors may vary from product photos.